Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892755) titled 'Liquid Biopsy-Based Early Screening for Endometrial Cancer in Regional Chinese Populations' on Oct. 18.

Study Type: Observational

Primary Sponsor: Guizhou Provincial People's Hospital

Condition: Endometrial Cancer Atypical Endometrial Hyperplasia

Recruitment Status: Recruiting

Date of First Enrollment: August 10, 2026

Target Sample Size: 512

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07892755

Disclaimer: Curated by HT Syndication....